Axo-myelinic neurotransmission: a novel mode of cell signalling in the central nervous system.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

31 citing papers in PubMed.

1. Characterizing Combined Central and Peripheral Demyelination-Insights From a Multimodal Comparison With Chronic Inflammatory Demyelinating Polyneuropathy and Multiple Sclerosis.Muscle & nerve · 2026
   Article
2. The Fragile X Messenger Ribonucleoprotein 1 Regulates the Morphology and Maturation of Human and Rat Oligodendrocytes.Glia · 2025
   Article
3. Oligodendroglia and Myelin: Supporting the Connectome.Advances in neurobiology · 2025
   Review
4. Cortical white matter: no longer a silent partner.Frontiers in neuroanatomy · 2025
   Review
5. Dynamic imaging of myelin pathology in physiologically preserved human brain tissue using third harmonic generation microscopy.PloS one · 2025
   Article
6. An Overview of Oligodendrocyte Metabolism.Advances in neurobiology · 2025
   Review
7. Single nucleus RNA sequencing reveals glial cell type-specific responses to ischemic stroke.bioRxiv : the preprint server for biology · 2023
   Article
8. Potential physiological and pathological roles for axonal ryanodine receptors.Neural regeneration research · 2023
   Review
9. Roles of neuroligins in central nervous system development: focus on glial neuroligins and neuron neuroligins.Journal of translational medicine · 2022
   Review
10. Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics.Journal of neuroinflammation · 2022
    Review
11. Functions and dysfunctions of oligodendrocytes in neurodegenerative diseases.Frontiers in cellular neuroscience · 2022
    Review
12. Engine Failure in Axo-Myelinic Signaling: A Potential Key Player in the Pathogenesis of Multiple Sclerosis.Frontiers in cellular neuroscience · 2021
    Review
13. Editorial: "Inside-Out" vs "Outside-In" Paradigms in Multiple Sclerosis Etiopathogenesis.Frontiers in cellular neuroscience · 2021
    Article
14. Neuron-Oligodendrocyte Interactions in the Structure and Integrity of Axons.Frontiers in cell and developmental biology · 2021
    Review
15. Neuroglia in Psychiatric Disorders.Advances in neurobiology · 2021
    Article
16. Neuron to Oligodendrocyte Precursor Cell Synapses: Protagonists in Oligodendrocyte Development and Myelination, and Targets for Therapeutics.Frontiers in neuroscience · 2021
    Review
17. Experimentally Induced Sepsis Causes Extensive Hypomyelination in the Prefrontal Cortex and Hippocampus in Neonatal Rats.Neuromolecular medicine · 2020
    Article
18. CX3CL1/CX3CR1 axis attenuates early brain injury via promoting the delivery of exosomal microRNA-124 from neuron to microglia after subarachnoid hemorrhage.Journal of neuroinflammation · 2020
    Article
19. Neuronal activity disrupts myelinated axon integrity in the absence of NKCC1b.The Journal of cell biology · 2020
    Article
20. Glutamate Transporters: Expression and Function in Oligodendrocytes.Neurochemical research · 2020
    Article

Corrections and comments

• Erratum for
  Axo-myelinic neurotransmission: a novel mode of cell signalling in the central nervous system.2018

Authors and funding

5 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract